Pertrochanter Arthroplasty Versus Osteosynthesis (PAVO)

September 3, 2019 updated by: Centre Hospitalier Universitaire Dijon

Comparison of Functional Recovery After Pertrochanter Fracture Treated With Either Total Hip Replacement or Centromedullary Nailing

This is a single-centre, comparative, prospective randomised trial. It will include 70 patients over a period of 2 years randomized into two groups of 35 patients: one group of patients treated with osteosynthesis (plate, nail or screw) and the second group treated with total hip replacement.

The Harris and PMA functional scores will be assessed at 6 weeks, 3 months, 6 months and 1 year.

The time to recovery of weight-bearing, the subjective satisfaction score, the EQ5D quality of life questionnaire, the VAS score for pain at rest and when walking, the Parker score, the rate of complications and deaths will also be measured. Operating time, blood loss and scar size will also be evaluated.

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dijon, France, 21079
        • CHU de Dijon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who have provided written informed consent
  • Patients over 18 years old
  • Patients less than 70 years old
  • Patient presenting with a fracture of the trochanter (type 1 to 6 according to the Ender classification, and A1 and A2 according tyo the AO classification (Association suisse pour l'étude de l'Ostéosynthèse : classification internationale)

Exclusion Criteria:

  • Adult under guardianship
  • Patients not covered by national health insurance
  • Pregnant or breast-feeding women
  • Unable to walk independently before the trauma
  • Patients with dementia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Patients treated with osteosynthesis
EXPERIMENTAL: Patients treated with total hip replacement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Harris Score
Time Frame: At 6 months after surgery
Functional hip score
At 6 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PMA functional score
Time Frame: Up to 1 year after surgery
Functional score
Up to 1 year after surgery
Time to recovery of weight-bearing
Time Frame: Up to 1 year after surgery
Up to 1 year after surgery
Subjective satisfaction score (EQ5D, VAS score for pain at rest and when walking)
Time Frame: Up to 1 year after surgery
Up to 1 year after surgery
Parker score
Time Frame: Up to 1 year after surgery
Score autonomy
Up to 1 year after surgery
Rate of complications (loosening of implants, fractures around osteosynthesis devices or prostheses, infections, phlebitis-pulmonary embolism)
Time Frame: Up to 1 year after surgery
Up to 1 year after surgery
Death rate
Time Frame: Up to 1 year after surgery
Up to 1 year after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 29, 2015

Primary Completion (ACTUAL)

October 21, 2018

Study Completion (ACTUAL)

October 21, 2018

Study Registration Dates

First Submitted

June 18, 2014

First Submitted That Met QC Criteria

June 20, 2014

First Posted (ESTIMATE)

June 24, 2014

Study Record Updates

Last Update Posted (ACTUAL)

September 4, 2019

Last Update Submitted That Met QC Criteria

September 3, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TREMLET AOI 2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pertrochanter Fracture

Clinical Trials on Osteosynthesis

Subscribe